Darwin Global Management, Ltd. 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Darwin Global Management, Ltd. disclosed 5 US equity positions worth $2.4bn in its Q2 2025 13F filing. The largest position was INSM at 80.8% of the reported book, followed by VRNA and CDTX. Against the Q1 2025 filing, it opened 2 new positions, added to 2 and reduced 0 among the top 5 holdings.
What did Darwin Global Management, Ltd. own in Q2 2025? Top 5 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 80.8% | $1.9bn | 19,344,621 | 26% | added |
| 2 | VRNA VERONA PHARMA PLC | 16.3% | $387.4m | 4,129,618 | 5% | added | |
| 3 | CDTX CIDARA THERAPEUTICS INC | 1.6% | $38.0m | 768,424 | – | new | |
| 4 | MERUS N V | 0.9% | $21.0m | 395,738 | – | new | |
| 5 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.5% | $12.4m | 10,479,791 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.